# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047441
Filing Date
2024-11-13
Accepted
2024-11-13 08:50:52
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrsn-20240930.htm iXBRL | 10-Q | 1425273
2 | EX-31.1 | exhibit31110-qfy2024q3.htm | EX-31.1 | 11102
3 | EX-31.2 | exhibit31210-qfy2024q3.htm | EX-31.2 | 11120
4 | EX-32.1 | exhibit32110-qfy2024q3.htm | EX-32.1 | 5750
| Complete submission text file | 0001628280-24-047441.txt |  | 6245002

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrsn-20240930.xsd | EX-101.SCH | 39875
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrsn-20240930_cal.xml | EX-101.CAL | 52747
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrsn-20240930_def.xml | EX-101.DEF | 161121
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrsn-20240930_lab.xml | EX-101.LAB | 536632
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrsn-20240930_pre.xml | EX-101.PRE | 385771
80 | EXTRACTED XBRL INSTANCE DOCUMENT | mrsn-20240930_htm.xml | XML | 719897

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 241451391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)